When was Ongentys approved by the FDA?

Written by Teresa Carvalho, MS |

A

When was Ongentys approved by the FDA?

Category: Ongentys

In the U.S., Ongentys was approved in April 2020 as an add-on treatment for off periods in Parkinson’s patients on levodopa/carbidopa.

Teresa Carvalho, MS avatar

About the Author

Teresa Carvalho, MS Teresa holds her Master of Science in cell and molecular biology from Coimbra University, Portugal. She was a researcher and science communicator for several years at the Institute for Research and Innovation in Health in Oporto, Portugal. From 2013, she has held a fellowship working with Pulmonary Hypertension Europe as a patient advocate, social media/website manager, public relations officer, and translator. Her work has been focused on providing patients access to treatments, raising awareness for pulmonary hypertension, and promoting patient empowerment.


Recommended reading